로딩 중...
52주 최고가 대비 76.7% 위치
Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other Operations. The company offers laboratory instruments, such as laboratory balances, liquid pipetting solutions, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, density and refractometry instruments, and thermal analysis systems; and other analytical instruments, including UV/VIS spectrophotometers, moisture analyzers, and cell counters, as well as LabX, a laboratory software platform to manage and analyze data generated by its instruments and automate workflows. It also provides industrial instruments comprising industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detectors, x-ray systems, checkweighers, and camera-based imaging equipment. In addition, the company offers retail weighing solutions consisting of weighing and software solutions, AI-driven image recognition solutions for fresh goods, and automated packaging and labeling solutions for the meat backroom. The company serves pharmaceutical and biotech companies, independent research organizations, and testing labs; food manufacturers and retailers; chemical, specialty chemicals, and cosmetics companies; transportation and logistics, metals, and electronics industries; and academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is headquartered in Greifensee, Switzerland.
SEC 13F 공시 기준 · 2026-Q1
SEC 13F 공시 기준 데이터입니다. 실제 현재 보유 현황과 다를 수 있으며, 투자 자문·권유·추천이 아닙니다.
| 재무 항목 | 2022년 | 2023년 | 2024년 | 2025년 |
|---|---|---|---|---|
| 주요 재무실적 (USD) | ||||
| 매출액 | $3.92B | $3.79B | $3.87B | $4.03B |
| 영업이익 | $1.13B | $1.08B | $1.13B | $1.12B |
| 당기순이익 | $872.5M | $788.8M | $863.1M | $869.2M |
| 잉여현금흐름 (FCF) | $737.8M | $860.6M | $864.4M | $848.6M |
| 수익성 비율 | ||||
| 영업이익률 | 28.7% | 28.5% | 29.1% | 27.8% |
| 순이익률 | 22.3% | 20.8% | 22.3% | 21.6% |
| ROE (자기자본이익률) | 3519.1% | -526.1% | -680.2% | -3677.4% |
| ROA (자산이익률) | 25.0% | 23.5% | 26.6% | 23.4% |
| 성장성 비율 | ||||
| 매출 성장률 (YoY) | - | -3.4% | 2.2% | 4.0% |
| EPS 성장률 (YoY) | - | -6.5% | 12.8% | 3.9% |
| 투자 지표 & 가치배수 | ||||
| PER (주가수익배수) | 39.9x | 33.3x | 33.7x | 32.7x |
| PBR (주가순자산배수) | 1249.4x | - | - | - |
| PSR (주가매출배수) | 7.9x | 6.4x | 7.1x | 6.9x |
| FCF Yield | 2.4% | 3.6% | 3.1% | 3.1% |
| 재무 건전성 (안정성) | ||||
| 부채비율 (D/E) | 81.25 | -13.88 | -15.87 | -91.05 |
| 유동비율 | 1.20 | 1.04 | 1.02 | 1.14 |
MOLINA HEALTHCARE INC
$179.86
$9.4B